Haemonetics Corp (HAE) stock
HAENYSESurgical & Medical Instruments & ApparatusFiscal year ends April 3
Financials through Q2 FY2027, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3064% above fair value
$122.94+0.23 (+0.19%)
Close on Nov 13, 2026Market cap $5.59BP/E 54.9Yield –
Haemonetics gross margin
Gross margin is gross profit as a percentage of revenue.
Haemonetics's gross margin for the twelve months ending Sep 26, 2026 was 59.6%. For fiscal 2026 it was 59.0%, against 55.0% the year before. The highest annual figure on record is 59.0% in fiscal 2026.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Mar 28, 2026 | 59.0% | +4.0 |
| FY2025 | Mar 29, 2025 | 55.0% | +2.2 |
| FY2024 | Mar 30, 2024 | 52.8% | +0.2 |
| FY2023 | Apr 1, 2023 | 52.6% | +1.7 |
| FY2022 | Apr 2, 2022 | 50.9% | +5.2 |
| FY2021 | Apr 3, 2021 | 45.7% | −3.3 |
| FY2020 | Mar 28, 2020 | 49.0% | +5.9 |
| FY2019 | Mar 30, 2019 | 43.2% | −2.4 |
| FY2018 | Mar 31, 2018 | 45.6% | +2.9 |
| FY2017 | Apr 1, 2017 | 42.7% | −1.9 |
| FY2016 | Apr 2, 2016 | 44.7% | −3.1 |
| FY2015 | Mar 28, 2015 | 47.7% | −2.2 |
| FY2014 | Mar 29, 2014 | 49.9% | +1.9 |
| FY2013 | Mar 30, 2013 | 48.0% | −2.7 |
| FY2012 | Mar 31, 2012 | 50.7% | −1.8 |
| FY2011 | Apr 2, 2011 | 52.5% | +0.2 |
| FY2010 | Apr 3, 2010 | 52.3% | +0.7 |
| FY2009 | Mar 28, 2009 | 51.5% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2027CQ3 2026 | Sep 26, 2026 | 61.7% | +2.3 |
| Q1 FY2027CQ2 2026 | Jun 27, 2026 | 59.8% | −0.1 |
| Q4 FY2026CQ1 2026 | Mar 28, 2026 | 57.2% | −1.2 |
| Q3 FY2026CQ4 2025 | Dec 27, 2025 | 59.7% | +4.2 |
| Q2 FY2026CQ3 2025 | Sep 27, 2025 | 59.5% | +5.2 |
| Q1 FY2026CQ2 2025 | Jun 28, 2025 | 59.8% | +7.8 |
| Q4 FY2025CQ1 2025 | Mar 29, 2025 | 58.4% | +7.2 |
| Q3 FY2025CQ4 2024 | Dec 28, 2024 | 55.5% | +2.6 |
| Q2 FY2025CQ3 2024 | Sep 28, 2024 | 54.2% | +0.7 |
| Q1 FY2025CQ2 2024 | Jun 29, 2024 | 52.0% | −1.7 |
| Q4 FY2024CQ1 2024 | Mar 30, 2024 | 51.2% | −0.1 |
| Q3 FY2024CQ4 2023 | Dec 30, 2023 | 52.9% | +0.9 |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | 53.6% | +0.5 |
| Q1 FY2024CQ2 2023 | Jul 1, 2023 | 53.7% | −0.7 |
| Q4 FY2023CQ1 2023 | Apr 1, 2023 | 51.3% | −0.1 |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | 52.0% | −1.4 |
| Q2 FY2023CQ3 2022 | Oct 1, 2022 | 53.1% | +2.0 |
| Q1 FY2023CQ2 2022 | Jul 2, 2022 | 54.4% | +7.1 |
| Q4 FY2022CQ1 2022 | Apr 2, 2022 | 51.4% | +15.1 |
| Q3 FY2022CQ4 2021 | Jan 1, 2022 | 53.3% | +3.3 |
| Q2 FY2022CQ3 2021 | Oct 2, 2021 | 51.1% | +0.6 |
| Q1 FY2022CQ2 2021 | Jul 3, 2021 | 47.3% | +1.3 |
| Q4 FY2021CQ1 2021 | Apr 3, 2021 | 36.4% | −11.3 |
| Q3 FY2021CQ4 2020 | Dec 26, 2020 | 50.0% | +0.6 |
| Q2 FY2021CQ3 2020 | Sep 26, 2020 | 50.5% | +0.2 |
| Q1 FY2021CQ2 2020 | Jun 27, 2020 | 46.0% | −2.6 |
| Q4 FY2020CQ1 2020 | Mar 28, 2020 | 47.6% | +3.0 |
| Q3 FY2020CQ4 2019 | Dec 28, 2019 | 49.4% | +4.5 |
| Q2 FY2020CQ3 2019 | Sep 28, 2019 | 50.3% | +4.0 |
| Q1 FY2020CQ2 2019 | Jun 29, 2019 | 48.6% | +12.3 |
| Q4 FY2019CQ1 2019 | Mar 30, 2019 | 44.6% | −0.1 |
| Q3 FY2019CQ4 2018 | Dec 29, 2018 | 44.9% | −2.6 |
| Q2 FY2019CQ3 2018 | Sep 29, 2018 | 46.3% | −0.1 |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | 36.3% | −7.2 |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | 44.7% | +8.7 |
| Q3 FY2018CQ4 2017 | Dec 30, 2017 | 47.6% | +3.2 |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | 46.4% | – |
| Q1 FY2018CQ2 2017 | Jul 1, 2017 | 43.5% | – |
| Q4 FY2017CQ1 2017 | Apr 1, 2017 | 36.0% | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | 44.4% | – |
See a number that looks wrong?